Channing Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-36,974
Closed -$7.17M 110
2024
Q3
$7.17M Sell
36,974
-691
-2% -$145K 0.18% 96
2024
Q2
$8.73M Sell
37,665
-738
-2% -$160K 0.24% 75
2024
Q1
$8.28M Buy
38,403
+4,300
+13% +$1.01M 0.22% 81
2023
Q4
$8.82M Buy
34,103
+4,077
+14% +$1M 0.26% 66
2023
Q3
$7.72M Buy
+30,026
New +$8.03M 0.25% 71
2018
Q3
Sell
-26,500
Closed -$7.69M 104
2018
Q2
$7.69M Sell
26,500
-3,729
-12% -$1.05M 0.27% 77
2018
Q1
$8.28M Buy
30,229
+4,468
+17% +$1.39M 0.29% 74
2017
Q4
$8.21M Buy
25,761
+1
+0% +$321 0.28% 77
2017
Q3
$8.07M Sell
25,760
-897
-3% -$266K 0.3% 78
2017
Q2
$7.23M Buy
26,657
+1,909
+8% +$505K 0.28% 79
2017
Q1
$6.77M Buy
24,748
+1,725
+7% +$488K 0.25% 84
2016
Q4
$6.53M Sell
23,023
-7,113
-24% -$2.11M 0.23% 85
2016
Q3
$9.43M Hold
30,136
0.38% 66
2016
Q2
$7.29M Buy
30,136
+6,883
+30% +$1.81M 0.31% 81
2016
Q1
$6.05M Buy
+23,253
New +$6.14M 0.27% 79

Other funds holding BIIB